Los puntos clave no están disponibles para este artículo en este momento.
We describe distinct clinical outcomes and recurrence rates associated with meningioma molecular subgroups. Our findings emphasize the importance of genomic characterization to guide postoperative management decisions for meningiomas.
Youngblood et al. (Mon,) studied this question.